CIK 0001388320 · Non-accelerated filer<br>Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880378336
- Phone
- (646) 677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-K Report Annual Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Executive Chairman bought 5,000 shares at $0.88 ($4,400)
- 8-K Event Shareholder vote results
- 8-K Event Material agreement
- DEFA14A Proxy Proxy Materials
- 4 Open-market buy Executive Chairman bought 5,000 shares at $0.98 ($4,900)
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Regulation FD disclosure
- 424B5 Offering Prospectus
Page 15 of 26 · 511 filings